OakChart

Mobile health Network Solutions

MNDRHealthcare·Health Information Services·Singapore·Nano·NASD·Nov 11 • 12:56 PM ET

0.9739+0.0212 (2.23%)
2026-11-11 18:58 CET
Market cap
1.14 USD m
Revenue, TTM
6.03 USD m
Net income, TTM
-2.49 USD m
Free cash flow, TTM
- USD m
EPS diluted, TTM
-3.69
P/E
-
Compare

Price

MNDR against its 20, 50 and 200-day averages
2050200
0.005.0010.0096.3M192.5MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26MNDRclose 0.9720-day 0.9450-day 1.21200-day 3.570.97

97.0% under the 52-week high of 32.52 on 21 Nov 2025. 52-week low 0.71 on 19 Oct 2026. Last 15 sessions, 27.4% high to low

Profile

MNDR
52-week range, 1% of the way up
0.7132.52

Mobile-health Network Solutions is an investment holding company, which engages in the provision of telehealth solutions through MaNaDr platform. The platform seeks to offer users the ability to teleconsult with doctors and prescribe and deliver medication at their doorsteps. It operates through the Telemedicine and Other Services and Sale of Medicine and Medical Devices. The Telemedicine and Other Services segment includes providing teleconsultation services to patients from both private and public sector. The Sale of Medicine and Medical Devices segment focuses on selling prescription drugs, non-prescription drugs, and healthcare products to clinics and end customers offline and online. The company was founded by Tung Yeng Siaw and Pui Pui Teoh on July 28, 2016 and is headquartered in Singapore.

Employees69
IPOApr 10, 2024
Beta-0.82
ATR, 14d0.23
Rel volume0.07
Short float18.52%
Insider own64.06%
Inst own2.95%

Snapshot

6 groups

Valuation

Index-
Market Cap1.17M
Enterprise Value-0.67M
Income-2.49M
Sales6.03M
Book/sh5.52
Cash/sh1.65
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees69
IPOApr 10, 2024

Ratios

P/E-
Forward P/E-
PEG-
P/S0.19
P/B0.18
P/C0.59
P/FCF-
EV/EBITDA-
EV/Sales-0.11
Quick Ratio3.88
Current Ratio3.97
Debt/Eq0.02
LT Debt/Eq0.01
Option/ShortNo / Yes

Earnings

EPS (ttm)-3.69
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y38.24% -3.80%
Sales past 3/5Y1.48% 25.74%
EPS Y/Y TTM92.03%
Sales Y/Y TTM4.47%
EPS Q/Q96.50%
Sales Q/Q16.55%
Earnings-
EPS/Sales Surpr.- -

Ownership

Insider Own64.06%
Insider Trans0.00%
Inst Own2.95%
Inst Trans15.44%
ROA-40.53%
ROE-51.30%
ROIC-32.34%
Gross Margin-15.38%
Oper. Margin-41.49%
Profit Margin-41.27%
SMA203.77%
SMA50-19.73%
SMA200-72.70%
Trades-

Technical

Shs Outstand1.08M
Shs Float0.43M
Short Float18.52%
Short Ratio0.02
Short Interest0.08M
52W High32.52 -97.01%
52W Low0.71 36.98%
Volatility10.09% 20.34%
ATR (14)0.23
RSI (14)47.17
Beta-0.82
Rel Volume0.07
Avg Volume3.49M
Volume132,240

Performance

Perf Week1.02%
Perf Month-33.29%
Perf Quarter-40.80%
Perf Half Y-84.09%
Perf YTD-81.82%
Perf Year-91.27%
Perf 3Y-
Perf 5Y-
Perf 10Y-
Recom1.00
Target Price1920.00
Prev Close0.95
Price0.97
Change %2.23%

Peers

Mkt cap
TickerCompanyMkt cap
AMWLAmerican Well Corp210.86M
TDOCTeladoc Health Inc1.65B
LFMDLifeMD Inc81.70M
MGRXMangoceuticals Inc4.34M
POMPomdoctor Ltd13.33M
DRIODarioHealth Corp25.48M
ZCMDZhongchao Inc4.26M
HCTIHealthcare Triangle Inc3.89M
BMGLBasel Medical Group Ltd8.81M
YI111 Inc ADR15.21M

News

latest 14 of 146
  • Mobile-health Network Solutions Launches MaNaDr Health Operating Ecosystem Connecting AI-Powered Virtual and In-Person Care (Newsfile)
  • Mobile-health Network Solutions Reports FY2026 Results, Highlights Investments in AI, Advances Ghana Expansion, and Launches MaNaDr Health Operating Ecosystem for Global Rollout (Newsfile)
  • Mobile-health Network Solutions Advances AI-Powered Lab Data Analysis to Transform Clinical Decision-Making (Newsfile)
  • MNDR and Jospong Form Exclusive Joint Venture to Launch AI-Powered Digital Healthcare Ecosystem in Ghana (Newsfile) -16.51%
  • MNDR Wins 2026 Technology for Good Award, Featuring Aiko in Its AI Intelligent Healthcare Ecosystem (Newsfile)
  • Loading…
  • Mobile-health Network Solutions Announces Effective Date of Reverse Stock Split (Newsfile) +9.34%
  • CORRECTION FROM SOURCE: Mobile-health Network Solutions Expands into Cybersecurity with Skylink-Contfinity Partnership, Launching OtterSG Bundled Solution for Clinics in Singapore (Newsfile) -17.25%
  • Mobile-health Network Solutions Expands into Cybersecurity with Skylink-Contfinity Partnership, Launching OttterSG Bundled Solution for Clinics in Singapore (Newsfile)
  • Mobile-health Network Solutions Announces Change in Effective Date of Reverse Stock Split (Newsfile) -8.94%
  • Mobile-health Network Solutions Enters into Non-Binding Strategic Memorandum to Facilitate Up to US$100 Million in Private Equity Funding for AI-Powered Healthcare Expansion (Newsfile)
  • Mobile-health Network Solutions Enters into Non-Binding US$119 Million Strategic Framework with Hector Capital to Acquire BIMA and M&M Helix, Accelerating AI-powered Healthcare Expansion across Asia and Africa (Newsfile) +26.32%
  • MNDR Lands $126M AI Data Center Deal But 65% Ownership Shift Raises Big Questions (InvestorsHub)
  • Mobile-health Network Solutions and Dato' Stanley Ling Announce Strategic US$126 Million Investment to Build Phased 60 MW AI Data Center Campus (Newsfile)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
No quarterly earnings.

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2024FY-134.4-31.200-13.9714.30
2025FY--9.600-86.500-25.90
2026FY-4.800-3.915-45.70

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2025FYS2024-10-2510025.9025.9025.90
2025FYS2024-10-2410025.9025.9025.90
2025FYS2024-10-2310025.9025.9025.90
2025FYS2024-10-2210025.9025.9025.90
2025FYS2024-10-2110025.9025.9025.90
2025FYS2024-10-2010025.9025.9025.90
2025FYS2024-10-1910025.9025.9025.90
2025FYS2024-10-1810025.9025.9025.90
2025FYS2024-10-1710025.9025.9025.90
2025FYS2024-10-1610025.9025.9025.90
2025FYS2024-10-1510025.9025.9025.90
2025FYS2024-10-1410025.9025.9025.90
2025FYS2024-10-1310025.9025.9025.90
2025FYS2024-10-1210025.9025.9025.90

Estimate history

EPS, annual-3.2480.482-16.62-99.853-86.5-3.915
Period202120222023202420252026
EPS, quarterly
Period
Sales, annual1.9185.1395.7710.3585.7726.029
Period202120222023202420252026
Sales, quarterly
Period
Shares, annual0.1420.1420.1420.1440.0351.386
Period202120222023202420252026
Shares, quarterly
Period

Income statement, annual

Currency USD, millions
MetricTTM2026FY2025FY2024FY2023FY2022FY2021FY
Total Revenue6.036.035.7710.365.775.141.92
Cost of Goods Sold Incl. D&A6.966.956.4313.016.794.542.12
Gross Profit-0.93-0.92-0.66-2.65-1.020.60-0.20
Selling, General and Administrative Excl. Other1.571.572.018.991.390.450.27
Other Operating Expense0.000.000.000.000.000.000.00
Operating Income-2.50-2.50-2.68-11.64-2.410.14-0.47
Interest Expense----0.000.000.00
Unusual Expense0.000.000.000.000.000.000.00
Net Income Before Taxes-2.49-2.48-2.55-11.58-2.350.19-0.46
Income Taxes0.000.000.00-0.010.000.12-0.00
Consolidated Net Income-2.49-2.48-2.55-11.57-2.350.07-0.46
Net Income From Continuing Operations-2.49-2.48-2.55-11.57-2.350.07-0.46
Net Income-2.49-2.48-2.55-11.57-2.350.07-0.46
EPS (Recurring)-1.80-3.92-86.50-99.85-16.620.48-3.25
EPS (Basic, Before Extraordinaries)-3.69-3.92-86.50-99.85-16.620.48-3.25
EPS (Diluted)-3.69-3.92-86.50-99.85-16.620.48-3.25
EBITDA-2.27-2.27-2.55-11.53-2.340.21-0.44
Non-Operating Income (Expense)0.010.010.120.060.060.050.01
Other After Tax Adjustments0.000.000.000.000.000.000.00
Stock Option Compensation Expense1.211.200.311.12---
Price To Sales Ratio0.700.320.163.79---
Gross Margin-15.38-15.29-11.45-25.60-17.6511.58-10.45
Operating Margin-41.49-41.40-46.36-112.42-41.762.77-24.76
Net Margin-41.27-41.17-44.25-111.70-40.811.33-23.99
Shares Outstanding1.391.390.030.140.140.140.14
Market Capitalization1.141.14139.6411,505.6011,505.60--

Income statement, quarterly

Currency USD, millions
Metric2026S22026S12025S22025S12024S22024S1
Total Revenue2.973.062.553.225.444.92
Cost of Goods Sold Incl. D&A4.002.962.733.707.585.44
Gross Profit-1.030.10-0.18-0.48-2.14-0.51
Selling, General and Administrative Excl. Other0.790.781.170.848.430.57
Other Operating Expense0.000.000.000.000.000.00
Operating Income-1.82-0.68-1.36-1.32-10.57-1.08
Interest Expense-----0.00
Unusual Expense0.000.000.000.000.000.00
Net Income Before Taxes-1.82-0.67-1.31-1.25-10.51-1.08
Income Taxes0.000.000.000.00-0.010.00
Consolidated Net Income-1.82-0.67-1.31-1.25-10.50-1.08
Net Income From Continuing Operations-1.82-0.67-1.31-1.25-10.50-1.08
Net Income-1.82-0.67-1.31-1.25-10.50-1.08
EPS (Recurring)-1.32-2.38-37.62-8.69-73.04-9.83
EPS (Basic, Before Extraordinaries)-1.32-2.38-37.62-8.69-73.04-9.83
EPS (Diluted)-1.32-2.38-37.62-8.69-73.04-9.83
EBITDA-1.69-0.58-1.28-1.27-10.51-1.03
Non-Operating Income (Expense)-0.000.010.050.070.060.00
Stock Option Compensation Expense1.180.020.310.001.13-
Price To Sales Ratio0.700.270.191.284.69-
Gross Margin-34.653.32-7.22-14.79-39.35-10.45
Operating Margin-61.37-22.22-53.27-40.92-194.41-22.04
Net Margin-61.41-21.74-51.26-38.73-193.06-22.00
Shares Outstanding1.390.580.030.140.14-
Market Capitalization1.146.58139.642,657.2411,505.6011,505.60

Balance sheet, annual

Currency USD, millions
Metric2026FY2025FY2024FY2023FY2022FY2021FY
Cash & Short Term Investments1.970.814.951.647.360.12
Short Term Receivables1.000.370.180.190.140.25
Inventories0.090.080.120.110.050.07
Other Current Assets1.270.130.130.060.020.02
Total Current Assets4.341.405.382.017.570.46
Net Property, Plant & Equipment0.170.240.430.420.070.10
Total Investments and Advances0.000.000.000.000.000.00
Long-Term Note Receivable-0.000.040.06--
Intangible Assets4.281.850.010.050.090.13
Deferred Tax Assets----0.000.00
Other Assets0.000.000.000.000.000.00
Total Assets8.793.495.872.547.730.69
Short Term Debt Incl. Current Port. of LT Debt0.080.130.280.110.030.02
Accounts Payable0.590.681.231.000.400.20
Income Tax Payable---0.000.100.00
Other Current Liabilities0.420.510.820.730.380.27
Total Current Liabilities1.091.332.331.850.910.49
Long Term Debt0.050.110.480.180.010.04
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.000.000.000.790.744.65
Total Liabilities1.141.442.812.821.675.18
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity7.652.053.05-0.276.06-4.48
Total Shareholders Equity7.652.053.05-0.276.06-4.48
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity7.652.053.05-0.276.06-4.48
Total Liabilities & Stockholders Equity8.793.495.872.547.730.69
Book Value Per Share5.5259.2121.25-1.9242.79-31.64
Tangible Book Value Per Share2.435.7921.16-2.2842.17-32.58
Full-Time Employees6973737358-
Price to Book Ratio0.1774.22----
Return on Assets-40.43-54.58-275.14-45.841.62-
Return on Equity-51.19-99.98-831.45-81.328.63-
Return on Invested Capital-32.26-117.96-327.19-1.12-
Quick Ratio3.880.992.261.038.250.80
Current Ratio3.971.062.311.098.310.94

Cash flow, annual

Currency USD, millions
MetricTTM2026FY2025FY2024FY2023FY2022FY2021FY
Net Income--2.48-2.55-11.57-2.350.07-0.46
Depreciation-0.230.130.110.070.060.03
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.00-0.00
Other Funds (Non Cash)-1.480.586.900.170.030.04
Funds from Operations--0.78-1.84-4.56-2.110.16-0.39
Extraordinary Item-0.000.000.000.000.000.00
Changes in Working Capital--0.41-1.45-0.190.460.55-0.08
Income Taxes Payable--0.000.00-0.100.10-0.00
Cash from Operating Activities--1.19-3.29-4.75-1.650.72-0.47
Capital Expenditures--1.50-1.84-0.10-0.14-0.01-0.00
Net Assets From Acquisitions-0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses-0.000.000.000.000.000.00
Purchase or Sale of Investments-0.000.000.000.000.000.00
Purchase of Investments-0.000.000.000.000.000.00
Sale Or Maturity of Investments-0.000.000.000.000.000.00
Other Uses--1.820.000.000.000.000.00
Other Sources-0.000.000.000.000.000.00
Cash from Investing Activities--3.32-1.84-0.10-0.14-0.01-0.00
Cash Dividends Paid-0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.00
Change in Capital Stock-5.900.748.05-4.227.140.00
Repurchase of Common Pref Stock-0.000.000.00-4.830.000.00
Sale of Common Pref Stock-5.900.748.050.627.140.00
Proceedsfrom Stock Options-5.900.748.050.627.140.00
Issuance or Reduction of Debt, Net-0.000.000.000.000.000.00
Change in Long Term Debt-0.000.000.000.000.000.00
Issuance of Long Term Debt-0.000.000.000.000.000.00
Reduction of Long Term Debt-0.000.000.000.000.000.00
Net Financing Active Other Cash Flow--0.11-0.020.02-0.03-0.350.39
Other Financing Activities Uses--0.11-0.020.00-0.03-0.35-0.11
Cash from Financing Activities-5.790.728.07-4.256.790.39
Exchange Rate Effect--0.100.120.100.16-0.080.00
Net Change in Cash-1.18-4.283.32-5.877.41-0.09
Free Cash Flow--1.19-3.34-4.85-1.780.71-0.48

Balance sheet, quarterly

Currency USD, millions
Metric2026S22026S12025S22025S12024S22024S1
Cash & Short Term Investments1.972.710.811.894.95-
Short Term Receivables1.000.280.370.120.18-
Inventories0.090.090.080.090.12-
Other Current Assets1.271.960.130.130.13-
Total Current Assets4.345.031.402.225.38-
Net Property, Plant & Equipment0.170.160.240.340.43-
Total Investments and Advances0.000.000.000.000.00-
Intangible Assets4.282.501.850.600.01-
Other Assets0.000.000.000.000.00-
Total Assets8.797.693.493.155.87-
Short Term Debt Incl. Current Port. of LT Debt0.080.070.130.260.28-
Accounts Payable0.590.770.680.541.23-
Other Current Liabilities0.420.350.510.290.82-
Total Current Liabilities1.091.191.331.092.33-
Long Term Debt0.050.020.110.200.48-
Other Liabilities0.000.000.000.000.00-
Total Liabilities1.141.211.441.292.81-
Non-Equity Reserves0.000.000.000.000.00-
Preferred Stock - Carrying Value0.000.000.000.000.00-
Common Equity7.656.472.051.863.05-
Total Shareholders Equity7.656.472.051.863.05-
Accumulated Minority Interest0.000.000.000.000.00-
Total Equity7.656.472.051.863.05-
Total Liabilities & Stockholders Equity8.797.693.493.155.87-
Book Value Per Share5.5211.1759.2112.9721.25-
Tangible Book Value Per Share2.436.865.798.8321.16-
Price to Book Ratio0.170.5474.22870.02--
Return on Assets-40.53-36.36-54.58---
Return on Equity-51.30-47.26-99.99---
Return on Invested Capital-23.69-10.24-60.29-60.52-296.87-
Quick Ratio3.884.150.991.962.26-
Current Ratio3.974.221.062.042.31-

Cash flow, quarterly

Currency USD, millions
Metric2026S22026S12025S22025S12024S22024S1

Revenue breakdown

Singapore2025: 7.65M 2026: 7.74M
Sale of Medicine and Medical Devices2025: 712.89K 2026: 673.46K
Telemedicine and Other Services2025: 6.93M 2026: 7.07M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3018.52%0.1M0.4M3.49M
2026-10-156.23%0.0M0.4M3.28M
2026-09-309.47%0.0M0.4M186.46K
2026-09-151.81%0.0M0.4M204.61K
2026-08-314.30%0.0M0.5M202.30K
2026-08-148.42%0.0M0.5M149.99K
2026-07-3113.89%0.1M0.5M410.36K
2026-07-154.42%0.0M0.5M426.17K
2026-06-3020.11%0.1M0.3M413.84K
2026-06-158.88%0.0M0.3M420.37K
2026-05-291.80%0.0M0.3M422.53K
2026-05-158.40%0.0M0.2M485.87K
2026-04-3024.82%0.1M0.2M184.70K
2026-04-150.52%0.0M0.5M191.69K
2026-03-313.76%0.0M0.4M190.96K
2026-03-132.27%0.0M0.4M117.13K
2026-02-275.13%0.0M0.4M167.78K
2026-02-130.41%0.0M0.4M582.18K
2026-01-301.64%0.0M0.4M578.99K
2026-01-150.86%0.0M0.4M539.00K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-3020-FRegistration statement under Section 12 of the Securities Exchange Act of 1934 or an annual or transition report filed under Section 13(a) or 15(d) of the Exchange Act for a foreign private issuer.2026-06-30SEC
2026-09-256-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-24SEC
2026-09-094Statement of changes in beneficial ownership of securities2026-08-27SEC
2026-09-094Statement of changes in beneficial ownership of securities2026-08-27SEC
2026-09-094Statement of changes in beneficial ownership of securities2026-08-27SEC
2026-08-186-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-18SEC
2026-08-126-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-12SEC
2026-06-186-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-18SEC
2026-06-096-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-09SEC
2026-05-186-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-18SEC
2026-05-136-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-13SEC
2026-05-06424B3SEC
2026-05-04EFFECTEffectiveness filing by commission orderSEC
2026-05-046-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-04SEC
2026-05-044Statement of changes in beneficial ownership of securities2026-04-30SEC
2026-05-044Statement of changes in beneficial ownership of securities2026-04-30SEC
2026-04-30CORRESPSEC
2026-04-286-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-04-28SEC
2026-04-246-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-04-24SEC
2026-04-24F-1/ASEC
2026-04-17F-1/ASEC
2026-04-146-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-04-14SEC
2026-04-136-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-04-13SEC
2026-04-13UPLOADUpload SubmissionSEC
2026-04-09F-1/ASEC
2026-04-09CORRESPSEC
2026-04-0920-F/A2025-06-30SEC
2026-03-303Initial statement of beneficial ownership of securities2026-03-18SEC
2026-03-25UPLOADUpload SubmissionSEC
2026-03-206-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-03-20SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
HRT FINANCIAL LP0.30%
CITADEL ADVISORS LLC0.19%
UBS Group AG0.14%
SBI Securities Co., Ltd.0.00%
Caitong International Asset Management Co., Ltd0.00%

Funds

Fund% owned
-

OakChart. MNDR. Cached 15 minutes.

Some panels did not load: ratings, insider.